Laura Philpot

Laura Philpot is a seasoned professional with extensive experience in the clinical trial industry, currently serving as Senior Manager of Global Feasibility and Trial Equity at Takeda since February 2022. Prior to this role, Laura held positions as Senior Manager of Global Trial Optimization at Regeneron Pharmaceuticals and Senior Manager of Global Feasibility at ICON plc, focusing on oncology and supporting site identification for sponsor trials. Earlier career highlights include serving as a Feasibility Analyst at Boehringer Ingelheim and various roles at PAREXEL, including Patient Recruitment Strategist and Clinical Feasibility Leader. Laura's academic background includes a Master's Degree in Educational Leadership and Administration from Oklahoma State University, a Bachelor's Degree in Communication and Media Studies from Appalachian State University, and a Certificate in Global Public Health from the University of North Carolina at Chapel Hill.